US Patent 7026293 Treatment or prophylaxis of ischemic heart disease
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 Nov, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Article (+699 characters)
Article
Patent abstract
The present invention provides a pharmaceutical composition and a method for reducing an infarct region resulting from the ischemic necrosis of cells, especially, a pharmaceutical composition and a method for suppressing ischemia-reperfusion injury in the treatment of ischemic heart disease. The pharmaceutical composition and the method utilize a substance, as an active ingredient, which can increase intracellular cGMP production by acting on a natriuretic peptide receptor, and which has the effect of reducing an infarct region. The substance is preferably a natriuretic peptide. The present invention is particularly useful for the treatment or prophylaxis of ischemic disease.
Infobox
Is a
Patent Jurisdiction
Patent Number
Patent Inventor Names
Masafumi Kitakaze0
Date of Patent
April 11, 2006
0Patent Application Number
097527240
Date Filed
January 3, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7026293 Treatment or prophylaxis of ischemic heart disease
Find more entities like US Patent 7026293 Treatment or prophylaxis of ischemic heart disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
